WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke PRÉNUMBRA wurde als Wortmarke am 11.08.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1555226 |
| Registernummer | 018202301 |
| Länder | 
|
| Basismarke |
Nr. 018202301,
27. Juni 2020
|
| Anmeldedatum | 11. August 2020 |
| Ablaufdatum | 11. August 2030 |
Markeninhaber
Devonshire House, 60 Goswell Road
London EC1M 7AD
GB
London EC1M 7AD
GB
Markenvertreter
Thierschstr. 11
80538 München
DE
Waren und Dienstleistungen
05
Pharmaceuticals; pharmaceutical drugs; pharmaceutical
preparations; pharmaceuticals used for cerebrovascular
accidents (strokes); cardiovascular preparations;
cardiovascular pharmaceuticals; cardiovascular
pharmaceutical preparations; cardiovascular agents for
medical purposes; cardiovascular drugs used in treating
shocks; cardiovascular drugs used in myocardial infarctions;
cardiovascular drugs used in treating arrhythmias;
cardiovascular drugs used in angina pectoris; pharmaceutical
preparations for the treatment of cardiovascular disease;
cardiovascular drugs used in treating congestive heart
failure (CHF); pharmaceutical preparations, preferably based
on analogues of melanocyte stimulating hormone (MSH), in
particular afamelanotide; sun tanning preparations for
pharmaceutical purposes, preferably based on analogues of
melanocyte stimulating hormone (MSH), in particular
afamelanotide; pharmaceutical preparations for skin care;
pharmaceutical preparations for treating skin disorders;
dermatological preparations; dermatological pharmaceutical
substances; dermatological pharmaceutical products;
medicinal creams for the protection of the skin; skin care
creams for medical use; skin care preparations for medical
use; medicated skin creams and lotions; medicated creams for
application after exposure to the sun; pharmaceutical skin
lotions; preparations for cleansing the skin for medical
use; chemical and biological preparations, substances,
reagents and compounds for the delivery and storage of
pharmaceuticals which are preferably based on analogues of
melanocyte stimulating hormone (MSH), in particular
afamelanotide; afamelanotide aqueous and gel formulations
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 17. Mai 2023 | 2023/21 Gaz | CA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. Mai 2023 | 2023/21 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| 07. Juni 2022 | 2022/23 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 24. März 2022 | 2022/13 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 31. Januar 2022 | 2022/6 Gaz | CA | Ablehnung |
| 07. November 2021 | 2021/45 Gaz | KR | Ablehnung |
| 14. September 2021 | 2021/37 Gaz | CH | Ablehnung |
| 02. September 2021 | 2021/40 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 27. Mai 2021 | 2021/21 Gaz | NZ | Ablehnung |
| 31. März 2021 | 2021/13 Gaz | SG | Ablehnung |
| 22. März 2021 | 2021/17 Gaz | RAW: Limitation | |
| 23. Februar 2021 | 2021/9 Gaz | CN | Ablehnung |
| 26. Januar 2021 | 2021/4 Gaz | AU | Ablehnung |
| 10. Januar 2021 | 2021/3 Gaz | IL | Ablehnung |
| 21. Dezember 2020 | 2020/52 Gaz | US | Ablehnung |
| 11. August 2020 | 2020/40 Gaz | EM | Eintragung |
ID: 141555226